Re: Toni K. Choueiri, Piotr Tomczak, Se Hoon Park, et al. Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma. N Engl J Med 2021;385:683–94: Adjuvant Pembrolizumab After Nephrectomy: A Plea to Reconsider the Need for Lymph Node Dissection
Gespeichert in:
| Veröffentlicht in: | European urology 2022-01, Vol.81 (1), p.e28-e28 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | e28 |
|---|---|
| container_issue | 1 |
| container_start_page | e28 |
| container_title | European urology |
| container_volume | 81 |
| creator | Capitanio, Umberto Larcher, Alessandro Montorsi, Francesco |
| description | |
| doi_str_mv | 10.1016/j.eururo.2021.09.034 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_2595119617</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0302283821021345</els_id><sourcerecordid>2595119617</sourcerecordid><originalsourceid>FETCH-LOGICAL-e181t-467bcaf7fb9e54b7c9063b8161b1dcc738de074f2613cb984ff91bb7d24eba183</originalsourceid><addsrcrecordid>eNp1kt2O0zAQhSMEYsvCGyA0l1xsgh3nxykSUhX2ByilWpZry3Ym1CWxi5Os1L3iHXhD3gMJV11ukLiyxvpmzvj4RNFzShJKaPFqm-DkJ--SlKQ0IVVCWPYgmlFesrjMC_IwmhFG0jjljJ9ET4ZhSwhhecUeRycsK7M053wW_b7GOdw4a-BDAvXGTWi8OYO1caMP972-k9_O4DPClXMW1tKHCkeQXQKLZjvdSjvCGnvlXWfupl4qkO2IHla423jUo-v3YCxco5VdXGPXQS29Ntb1MoEVnNuvHbyHj9jA4RmvGc_nBWe_fvyssvn_FBb_KgQS1h1KGF1Q0s4OpgnEuMFAhdGt87Dc97sNrFyD8NYMQ2g0zj6NHrWyG_DZ_Xkafbk4v6mv4uWny3f1Yhkj5XSMs6JUWrZlqyrMM1XqihRMcVpQRRutS8YbJGXWpgVlWlU8a9uKKlU2aYZKUs5Oo5fHuTvvvk84jKI3gw5uSItuGkSaVzmlVUHLgL64RyfVYyN23vTS78XfLwvAmyOAYeFbg14M2qDV2JiDHaJxRlAiDhkRW3HMiDiYK0glQkbYH1_fsM0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2595119617</pqid></control><display><type>article</type><title>Re: Toni K. Choueiri, Piotr Tomczak, Se Hoon Park, et al. Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma. N Engl J Med 2021;385:683–94: Adjuvant Pembrolizumab After Nephrectomy: A Plea to Reconsider the Need for Lymph Node Dissection</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Capitanio, Umberto ; Larcher, Alessandro ; Montorsi, Francesco</creator><creatorcontrib>Capitanio, Umberto ; Larcher, Alessandro ; Montorsi, Francesco</creatorcontrib><identifier>ISSN: 0302-2838</identifier><identifier>EISSN: 1873-7560</identifier><identifier>DOI: 10.1016/j.eururo.2021.09.034</identifier><identifier>PMID: 34742588</identifier><language>eng</language><publisher>Switzerland: Elsevier B.V</publisher><subject>Antibodies, Monoclonal, Humanized ; Carcinoma, Renal Cell - drug therapy ; Carcinoma, Renal Cell - pathology ; Carcinoma, Renal Cell - surgery ; Female ; Humans ; Kidney Neoplasms - drug therapy ; Kidney Neoplasms - pathology ; Kidney Neoplasms - surgery ; Lymph Node Excision ; Male ; Nephrectomy</subject><ispartof>European urology, 2022-01, Vol.81 (1), p.e28-e28</ispartof><rights>2021 European Association of Urology</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.eururo.2021.09.034$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34742588$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Capitanio, Umberto</creatorcontrib><creatorcontrib>Larcher, Alessandro</creatorcontrib><creatorcontrib>Montorsi, Francesco</creatorcontrib><title>Re: Toni K. Choueiri, Piotr Tomczak, Se Hoon Park, et al. Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma. N Engl J Med 2021;385:683–94: Adjuvant Pembrolizumab After Nephrectomy: A Plea to Reconsider the Need for Lymph Node Dissection</title><title>European urology</title><addtitle>Eur Urol</addtitle><subject>Antibodies, Monoclonal, Humanized</subject><subject>Carcinoma, Renal Cell - drug therapy</subject><subject>Carcinoma, Renal Cell - pathology</subject><subject>Carcinoma, Renal Cell - surgery</subject><subject>Female</subject><subject>Humans</subject><subject>Kidney Neoplasms - drug therapy</subject><subject>Kidney Neoplasms - pathology</subject><subject>Kidney Neoplasms - surgery</subject><subject>Lymph Node Excision</subject><subject>Male</subject><subject>Nephrectomy</subject><issn>0302-2838</issn><issn>1873-7560</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kt2O0zAQhSMEYsvCGyA0l1xsgh3nxykSUhX2ByilWpZry3Ym1CWxi5Os1L3iHXhD3gMJV11ukLiyxvpmzvj4RNFzShJKaPFqm-DkJ--SlKQ0IVVCWPYgmlFesrjMC_IwmhFG0jjljJ9ET4ZhSwhhecUeRycsK7M053wW_b7GOdw4a-BDAvXGTWi8OYO1caMP972-k9_O4DPClXMW1tKHCkeQXQKLZjvdSjvCGnvlXWfupl4qkO2IHla423jUo-v3YCxco5VdXGPXQS29Ntb1MoEVnNuvHbyHj9jA4RmvGc_nBWe_fvyssvn_FBb_KgQS1h1KGF1Q0s4OpgnEuMFAhdGt87Dc97sNrFyD8NYMQ2g0zj6NHrWyG_DZ_Xkafbk4v6mv4uWny3f1Yhkj5XSMs6JUWrZlqyrMM1XqihRMcVpQRRutS8YbJGXWpgVlWlU8a9uKKlU2aYZKUs5Oo5fHuTvvvk84jKI3gw5uSItuGkSaVzmlVUHLgL64RyfVYyN23vTS78XfLwvAmyOAYeFbg14M2qDV2JiDHaJxRlAiDhkRW3HMiDiYK0glQkbYH1_fsM0</recordid><startdate>202201</startdate><enddate>202201</enddate><creator>Capitanio, Umberto</creator><creator>Larcher, Alessandro</creator><creator>Montorsi, Francesco</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>202201</creationdate><title>Re: Toni K. Choueiri, Piotr Tomczak, Se Hoon Park, et al. Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma. N Engl J Med 2021;385:683–94: Adjuvant Pembrolizumab After Nephrectomy: A Plea to Reconsider the Need for Lymph Node Dissection</title><author>Capitanio, Umberto ; Larcher, Alessandro ; Montorsi, Francesco</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-e181t-467bcaf7fb9e54b7c9063b8161b1dcc738de074f2613cb984ff91bb7d24eba183</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Antibodies, Monoclonal, Humanized</topic><topic>Carcinoma, Renal Cell - drug therapy</topic><topic>Carcinoma, Renal Cell - pathology</topic><topic>Carcinoma, Renal Cell - surgery</topic><topic>Female</topic><topic>Humans</topic><topic>Kidney Neoplasms - drug therapy</topic><topic>Kidney Neoplasms - pathology</topic><topic>Kidney Neoplasms - surgery</topic><topic>Lymph Node Excision</topic><topic>Male</topic><topic>Nephrectomy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Capitanio, Umberto</creatorcontrib><creatorcontrib>Larcher, Alessandro</creatorcontrib><creatorcontrib>Montorsi, Francesco</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>European urology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Capitanio, Umberto</au><au>Larcher, Alessandro</au><au>Montorsi, Francesco</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Re: Toni K. Choueiri, Piotr Tomczak, Se Hoon Park, et al. Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma. N Engl J Med 2021;385:683–94: Adjuvant Pembrolizumab After Nephrectomy: A Plea to Reconsider the Need for Lymph Node Dissection</atitle><jtitle>European urology</jtitle><addtitle>Eur Urol</addtitle><date>2022-01</date><risdate>2022</risdate><volume>81</volume><issue>1</issue><spage>e28</spage><epage>e28</epage><pages>e28-e28</pages><issn>0302-2838</issn><eissn>1873-7560</eissn><cop>Switzerland</cop><pub>Elsevier B.V</pub><pmid>34742588</pmid><doi>10.1016/j.eururo.2021.09.034</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0302-2838 |
| ispartof | European urology, 2022-01, Vol.81 (1), p.e28-e28 |
| issn | 0302-2838 1873-7560 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2595119617 |
| source | MEDLINE; Access via ScienceDirect (Elsevier) |
| subjects | Antibodies, Monoclonal, Humanized Carcinoma, Renal Cell - drug therapy Carcinoma, Renal Cell - pathology Carcinoma, Renal Cell - surgery Female Humans Kidney Neoplasms - drug therapy Kidney Neoplasms - pathology Kidney Neoplasms - surgery Lymph Node Excision Male Nephrectomy |
| title | Re: Toni K. Choueiri, Piotr Tomczak, Se Hoon Park, et al. Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma. N Engl J Med 2021;385:683–94: Adjuvant Pembrolizumab After Nephrectomy: A Plea to Reconsider the Need for Lymph Node Dissection |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T11%3A52%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Re:%20Toni%20K.%20Choueiri,%20Piotr%20Tomczak,%20Se%20Hoon%20Park,%20et%20al.%20Adjuvant%20Pembrolizumab%20after%20Nephrectomy%20in%20Renal-Cell%20Carcinoma.%20N%20Engl%20J%20Med%202021;385:683%E2%80%9394:%20Adjuvant%20Pembrolizumab%20After%20Nephrectomy:%20A%20Plea%20to%20Reconsider%20the%20Need%20for%20Lymph%20Node%20Dissection&rft.jtitle=European%20urology&rft.au=Capitanio,%20Umberto&rft.date=2022-01&rft.volume=81&rft.issue=1&rft.spage=e28&rft.epage=e28&rft.pages=e28-e28&rft.issn=0302-2838&rft.eissn=1873-7560&rft_id=info:doi/10.1016/j.eururo.2021.09.034&rft_dat=%3Cproquest_pubme%3E2595119617%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2595119617&rft_id=info:pmid/34742588&rft_els_id=S0302283821021345&rfr_iscdi=true |